London, United Kingdom

Andrew Robert Mawby

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mallinckrodt, Inc.. Active years: 2015.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Andrew Robert Mawby

Introduction

Andrew Robert Mawby is a notable inventor based in London, Great Britain. He has made significant contributions to the field of pharmaceuticals through his innovative ideas and patent developments. With a keen focus on improving the management of medicaments, Mawby has demonstrated his dedication to enhancing healthcare solutions.

Latest Patents

Mawby holds a patent titled "Systems and methods for managing use of a medicament." This patented invention revolves around processes for managing the use of a pharmaceutical product. The system utilizes an external cover, a container, and a first material, all contained within an internal space when the external cover is closed relative to the container. The invention allows for the release of the first material, which may bond the external cover to the container or come into contact with the pharmaceutical product, thereby facilitating effective delivery.

Career Highlights

Currently, Andrew Robert Mawby is associated with Mallinckrodt, Inc., where he continues to advance his work in the pharmaceutical industry. His innovative spirit and commitment to improving medicinal use are evident throughout his career.

Collaborations

Mawby has worked alongside notable colleagues such as Vernon D. Ortenzi and Robert J. Ziemba. Together, they contribute to the development of groundbreaking technologies and solutions in the pharmaceutical sector.

Conclusion

Andrew Robert Mawby's work exemplifies the impactful role of inventors in healthcare innovation. His patent on systems for managing medicament use stands as a testament to his ingenuity and dedication to improving patient outcomes in the pharmaceutical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…